BPC-157 Heals Bone Defects in Rabbits as Effectively as Growth Factors

BPC-157 promoted healing of segmental bone defects in rabbits with osteogenic activity comparable to growth factors like IGF-1 and TGF-beta, demonstrating a new bone-healing application.

Sebecić, B et al.·Bone·1999·Moderate EvidenceAnimal StudyAnimal Study
RPEP-00555Animal StudyModerate Evidence1999RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

BPC-157 promoted segmental bone defect healing in rabbits with osteogenic activity comparable to IGF-1 and TGF-beta, demonstrating significant bone regeneration through angiogenic and osteoblast-stimulating mechanisms.

Key Numbers

How They Did This

Animal study in rabbits with surgically created segmental bone defects. BPC-157 was compared to EGF, IGF-1, and TGF-beta for bone regeneration. Histological and radiographic assessment of bone healing.

Why This Research Matters

A peptide that promotes bone healing could help millions with fractures, osteoporosis, and bone defects. BPC-157's comparable activity to established growth factors, combined with its good safety profile, makes it a promising bone therapy candidate.

The Bigger Picture

BPC-157's bone healing ability adds to its growing list of regenerative properties. A single peptide that promotes healing in gut, skin, muscle, AND bone is remarkable and suggests it activates fundamental repair mechanisms.

What This Study Doesn't Tell Us

Rabbit model; bone healing in rabbits may differ from humans. Single defect model may not represent all fracture types. Optimal dose and delivery method not fully established.

Questions This Raises

  • ?Could BPC-157 accelerate fracture healing in humans?
  • ?Does BPC-157's bone effect work through the same NO-mediated mechanism as its gut healing?
  • ?Would local BPC-157 application outperform systemic dosing for bone healing?

Trust & Context

Key Stat:
Matches growth factors BPC-157's bone healing was comparable to established growth factors IGF-1 and TGF-beta in a rabbit defect model
Evidence Grade:
Moderate evidence from a controlled animal study with comparative growth factor data and objective bone healing assessment.
Study Age:
Published in 1999. BPC-157's bone healing effects have been studied further, supporting its osteogenic properties.
Original Title:
Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation.
Published In:
Bone, 24(3), 195-202 (1999)
Database ID:
RPEP-00555

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Can BPC-157 heal bones?

In this rabbit study, BPC-157 promoted bone healing as effectively as established growth factors. It appears to work by stimulating blood vessel formation and bone cell activity at the fracture site.

Why might a stomach peptide help bones?

Patients who have their stomachs removed develop osteoporosis more often, suggesting the stomach produces bone-supporting factors. BPC-157, derived from a gastric protein, may be one such factor.

Read More on RethinkPeptides

Cite This Study

RPEP-00555·https://rethinkpeptides.com/research/RPEP-00555

APA

Sebecić, B; Nikolić, V; Sikirić, P; Seiwerth, S; Sosa, T; Patrlj, L; Grabarević, Z; Rucman, R; Petek, M; Konjevoda, P; Jadrijević, S; Perović, D; Slaj, M. (1999). Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation.. Bone, 24(3), 195-202.

MLA

Sebecić, B, et al. "Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation.." Bone, 1999.

RethinkPeptides

RethinkPeptides Research Database. "Osteogenic effect of a gastric pentadecapeptide, BPC-157, on..." RPEP-00555. Retrieved from https://rethinkpeptides.com/research/sebecic-1999-osteogenic-effect-of-a

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.